• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长春瑞滨(KW - 2307)与顺铂联合作用于体外培养的人肺腺癌PC - 12细胞的联合效应动力学分析。

Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture.

作者信息

Gomi K, Ohno H, Nomura K, Okabe M, Kobayashi K, Niitani H

机构信息

Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., Shizuoka-ken.

出版信息

Jpn J Cancer Res. 1992 May;83(5):532-9. doi: 10.1111/j.1349-7006.1992.tb01961.x.

DOI:10.1111/j.1349-7006.1992.tb01961.x
PMID:1618703
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5918847/
Abstract

The combination effect of navelbine (NVB, KW-2307), a newly synthesized vinca alkaloid, and cisplatin (CDDP) was compared with that of vindesine (VDS) and CDDP using human lung adenocarcinoma PC-12 cells. The growth-inhibitory activity of NVB or VDS was time-dependent, whereas that of CDDP was AUC (area under the curve)-dependent. When NVB or VDS was used in combination with CDDP simultaneously for 24 h, antagonism was observed in terms of growth-inhibitory activity. However, additive combination effect was observed when NVB or VDS treatment was followed by CDDP treatment. On this treatment schedule, a synergistic combination effect was observed in terms of the cell-killing activity assessed by colony formation assay. The growth-inhibitory activity of NVB or VDS was detected 24 h after the treatment, whereas that of CDDP became significant 72 h after the treatment. NVB and VDS caused cell accumulation in G2M phase at 10 times their IC80 values, and cells with less than diploid DNA content were detected after 24 h at IC80. CDDP caused accumulation of cells in S phase, and the effect became detectable 16 h after the treatment. The DNA histogram of cells treated with NVB or VDS in combination with CDDP was a superposition of those of cells treated with each drug alone. Significant differences in the characteristics of anticellular activity were not detected between NVB and VDS, although NVB inhibited cell growth at a slightly lower concentration than VDS at the short exposure time of 1-8 h.

摘要

使用人肺腺癌细胞PC - 12,比较了新合成的长春花生物碱去甲长春花碱(NVB,KW - 2307)与顺铂(CDDP)的联合效应以及长春地辛(VDS)与CDDP的联合效应。NVB或VDS的生长抑制活性呈时间依赖性,而CDDP的生长抑制活性呈曲线下面积(AUC)依赖性。当NVB或VDS与CDDP同时使用24小时时,在生长抑制活性方面观察到拮抗作用。然而,当NVB或VDS治疗后再进行CDDP治疗时,观察到相加联合效应。按照这种治疗方案,通过集落形成试验评估的细胞杀伤活性方面观察到协同联合效应。NVB或VDS的生长抑制活性在治疗后24小时检测到,而CDDP的生长抑制活性在治疗后72小时变得显著。NVB和VDS在其IC80值的10倍浓度时导致细胞在G2M期积累,并且在IC80浓度下24小时后检测到DNA含量低于二倍体的细胞。CDDP导致细胞在S期积累,并且在治疗后16小时可检测到该效应。用NVB或VDS与CDDP联合处理的细胞的DNA直方图是单独用每种药物处理的细胞的DNA直方图的叠加。尽管在1 - 8小时的短暴露时间下NVB比VDS以略低的浓度抑制细胞生长,但在NVB和VDS之间未检测到抗细胞活性特征的显著差异。

相似文献

1
Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture.长春瑞滨(KW - 2307)与顺铂联合作用于体外培养的人肺腺癌PC - 12细胞的联合效应动力学分析。
Jpn J Cancer Res. 1992 May;83(5):532-9. doi: 10.1111/j.1349-7006.1992.tb01961.x.
2
[Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer].[一项随机研究的结果:比较612例不可切除非小细胞肺癌患者中诺维本-顺铂联合方案、长春地辛-顺铂联合方案及单用诺维本的疗效]
Bull Cancer. 1996 May;83(5):385-94.
3
Combination effect of navelbine (vinorelbine ditartrate) with cisplatin against murine P388 leukemia and human lung carcinoma xenografts in mice.
Anticancer Drugs. 1993 Oct;4(5):577-83. doi: 10.1097/00001813-199310000-00008.
4
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.长春瑞滨与顺铂联合、长春地辛与顺铂联合及单用长春瑞滨治疗晚期非小细胞肺癌的随机研究:一项纳入612例患者的欧洲多中心试验结果
J Clin Oncol. 1994 Feb;12(2):360-7. doi: 10.1200/JCO.1994.12.2.360.
5
Clinical pharmacokinetics of vinorelbine alone and combined with cisplatin.长春瑞滨单药及与顺铂联合应用的临床药代动力学
J Clin Pharmacol. 1992 Dec;32(12):1096-8.
6
[A late phase-II trial comparing KW-2307 with vindesine in non-small cell lung cancer (1). Lung cancer section in KW-2307 Study Group].一项在非小细胞肺癌中比较KW-2307与长春地辛的II期晚期试验(1)。KW-2307研究组肺癌部分
Gan To Kagaku Ryoho. 1995 Jan;22(1):67-76.
7
Do all patients with advanced non-small-cell lung cancer benefit from cisplatin-based combination therapy?所有晚期非小细胞肺癌患者都能从以顺铂为基础的联合治疗中获益吗?
Ann Oncol. 2001 Dec;12(12):1667-70. doi: 10.1023/a:1013574413217.
8
[Clinical pharmacokinetics of vinca alkaloids].[长春花生物碱的临床药代动力学]
Bull Cancer. 1988;75(2):195-200.
9
The cost-effectiveness of navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in stage IV non-small cell lung cancer.与其他化疗方案及最佳支持治疗相比,长春瑞滨单药或联合顺铂用于IV期非小细胞肺癌治疗的成本效益。
Eur J Cancer. 1996 Dec;32A(13):2249-55. doi: 10.1016/s0959-8049(96)00298-5.
10
[A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC)].254-S联合长春地辛(VDS)与顺铂(CDDP)联合VDS治疗晚期非小细胞肺癌(NSCLC)的随机对照研究
Gan To Kagaku Ryoho. 1992 Jul;19(7):1019-26.

引用本文的文献

1
Vinorelbine: a review of its use in elderly patients with advanced non-small cell lung cancer.长春瑞滨:老年晚期非小细胞肺癌患者应用的综述
Drugs Aging. 2002;19(9):695-721. doi: 10.2165/00002512-200219090-00006.
2
Combined effect of navelbine with medroxyprogesterone acetate against human breast carcinoma MCF-7 cells in vitro.去甲长春花碱与醋酸甲羟孕酮联合对人乳腺癌MCF-7细胞的体外作用
Br J Cancer. 1998 Jun;77(11):1737-43. doi: 10.1038/bjc.1998.291.
3
Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.长春瑞滨。其药理特性及在癌症化疗中的临床应用综述。
Drugs Aging. 1994 Sep;5(3):200-34. doi: 10.2165/00002512-199405030-00006.

本文引用的文献

1
A new class of antitumor compounds: 5'-nor and 5',6'-seco derivatives of vinblastine-type alkaloids.一类新型抗肿瘤化合物:长春碱型生物碱的5'-降和5',6'-开环衍生物。
J Org Chem. 1979 Oct 1;44(22):3765-8. doi: 10.1021/jo01336a006.
2
Criteria for analyzing interactions between biologically active agents.分析生物活性剂之间相互作用的标准。
Adv Cancer Res. 1981;35:269-335. doi: 10.1016/s0065-230x(08)60912-4.
3
Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules.顺铂与长春地辛联合化疗治疗晚期肺癌:一项比较两种给药方案的随机试验。
Ann Intern Med. 1981 Oct;95(4):414-20. doi: 10.7326/0003-4819-95-4-414.
4
Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell lines.长春新碱或长春地辛对哺乳动物细胞系的细胞杀伤及动力学效应比较
J Natl Cancer Inst. 1981 Aug;67(2):437-43.
5
The effect of vinca alkaloids in enhancing the sensitivity of a methotrexate-resistant (L1210/R7A) line, studied by flow cytometric and chromosome number analysis.通过流式细胞术和染色体数分析研究长春花生物碱增强甲氨蝶呤耐药(L1210/R7A)细胞系敏感性的作用。
Cancer Chemother Pharmacol. 1984;13(1):47-53. doi: 10.1007/BF00401447.
6
Experimental antitumor activity of 5'-nor-anhydrovinblastine navelbine.5'-去甲-脱水长春碱(诺维本)的实验性抗肿瘤活性
Cancer Lett. 1984 Feb;22(1):49-54. doi: 10.1016/0304-3835(84)90042-9.
7
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.剂量-效应关系的定量分析:多种药物或酶抑制剂的联合效应
Adv Enzyme Regul. 1984;22:27-55. doi: 10.1016/0065-2571(84)90007-4.
8
Characteristics of antiviral and anticellular activities of human recombinant interferon-gamma.
Jpn J Cancer Res. 1985 Mar;76(3):224-34.
9
Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment.
Cancer Treat Rep. 1985 Apr;69(4):387-95.
10
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.转移性非小细胞肺癌四种最有效治疗方案的随机试验。
J Clin Oncol. 1986 Jan;4(1):14-22. doi: 10.1200/JCO.1986.4.1.14.